Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Grace Therapeutics (GRCE) Q2 2025 Earnings
GRCE
23
Jun
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.37
-0.21
-0.05
0.11
Details
Expected EPS
-0.2775
Actual EPS
0.11
Surprise EPS
0.39
Surprise Percent
+139.64%
Description
Grace Therapeutics (GRCE) has reported earnings of 0.11 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login